Table 4 Adjusted odds ratios for Luminal B, HER2 ⁺ enriched, and triple-negative tumors compared with having a Luminal A tumor

<40

1.04 (0.60, 1.79)

1.11 (0.58, 2.13)

0.94 (0.53, 1.65)

40–49

1

1

1

50–59

0.61 (0.36, 1.04)

1.08 (0.61, 1.91)

1.70 (1.09, 2.67)

60–69

0.54 (0.31, 0.96)

0.75 (0.40, 1.41)

0.78 (0.46, 1.33)

70–79

0.69 (0.38, 1.28)

0.69 (0.33, 1.46)

0.84 (0.47, 1.52)

≥80

0.30 (0.10, 0.91)

0.50 (0.16, 1.53)

0.84 (0.39, 1.81)

P _trend = 0.003

P _trend = 0.21

P _trend = 0.33

2006–2007

1

1

1

2008–2009

1.57 (0.83, 2.91)

0.93 (0.51, 1.69)

1.35 (0.76, 2.39)

2010–2012

1.00 (0.54, 1.85)

0.49 (0.27, 0.89)

1.12 (0.64, 1.94)

P _trend = 0.27

P _trend = 0.003

P _trend = 0.96

I–II

1

1

1

III–IV

1.41 (0.98, 2.04)

2.34 (1.53, 3.59)

1.67 (1.20, 2.32)

1

1

1

1

2

1.16 (0.59, 2.31)

2.54 (0.75, 8.59)

1.62 (0.73, 3.60)

3

2.35 (1.17, 4.73)

8.65 (2.59, 28.9)

7.70 (3.52, 16.8)

Missing

1.72 (0.74, 4.01)

4.61 (1.23, 17.26)

2.99 (1.21, 7.37)

Black

1

1

1

Nonblack^a

0.95 (0.52, 1.71)

0.40 (0.17, 0.96)

0.47 (0.24, 0.89)

White

1.02 (0.42, 2.44)

0.34 (0.08, 1.49)

0.50 (0.19, 1.35)

Colored

0.70 (0.26, 1.91)

0.44 (0.13, 1.53)

0.36 (0.12, 1.07)

Asian

1.37 (0.41, 4.30)

0.41 (0.05, 3.27)

0.63 (0.17, 2.32)